Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 2/2007

01-02-2007 | original article

End-stage heart failure and mechanical circulatory support: feasibility of discharge from hospital

Auteurs: A. Oosterom, N. de Jonge, J. H. Kirkels, B. F. M. Rodermans, E. Sukkel, C. Klöpping, F. Ramjankhan, J. R. Lahpor

Gepubliceerd in: Netherlands Heart Journal | Uitgave 2/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background. Due to the shortage of donor hearts, mechanical circulatory support is increasingly being used as a bridge to transplantation. In order to allow for more widespread use of ventricular assist devices it is mandatory that patients are not continuously hospitalised. We present the results of our experience with patients with end-stage heart failure, discharged from hospital after implantation of a ventricular assist device and followed in an outpatient setting.
Methods. After an intensive training and education programme, focusing on the management of the percutaneous driveline and instructions on how to handle in case of an alarm or malfunction of the device, patients were discharged. They were followed in the outpatient department. All regular and unplanned visits were registered, including readmissions.
Results. Twenty-seven patients treated with a ventricular assist device were discharged from hospital. There were 37 extra visits, of these, 27 were device related resulting in 21 readmissions (0.78/patient). We treated eight infectious episodes in four patients, all device related. Furthermore seven thromboembolic episodes occurred in four patients. One patient died because of multiorgan failure seven weeks after he was readmitted with an urosepsis. In our experience of 11.4 patient years at home while on the device, only 5% of the time was spent in hospital for complications. In comparison with patients on an assist device who stayed in hospital until transplantation, there were no more complications. Conclusion. This study demonstrates that patients with end-stage heart failure, treated with a ventricular assist device, can be safely discharged from hospital, with an acceptable rate of readmissions. It results in a fair quality of life, with a high degree of independence of the patient. (Neth Heart J 2007; 15:45-50.)
Literatuur
go back to reference Brophy JM, Joseph L, Rouleau JL. B-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Int Med 2001;134:550-60. Brophy JM, Joseph L, Rouleau JL. B-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Int Med 2001;134:550-60.
go back to reference Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al., for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al., for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
go back to reference Chatterjee K. Refractory heart failure- drugs and devices. Eur Heart J 2001;22:2227-30. Chatterjee K. Refractory heart failure- drugs and devices. Eur Heart J 2001;22:2227-30.
go back to reference Lahpor JR, de Jonge N, van Swieten HA, Wesenhagen H, Klöpping C, Geertman JH, et al. Left ventricular assist device as bridge to transplantation in patients with end-stage heart failure. Neth Heart J 2002;10:267-71. Lahpor JR, de Jonge N, van Swieten HA, Wesenhagen H, Klöpping C, Geertman JH, et al. Left ventricular assist device as bridge to transplantation in patients with end-stage heart failure. Neth Heart J 2002;10:267-71.
go back to reference de Jonge N, Kirkels H, Lahpor JR, Klopping C, Hulzebos EJ, de la Riviere AB, et al. Exercise performance in patients with endstage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting? J Am Coll Cardiol 200137:1794-9. de Jonge N, Kirkels H, Lahpor JR, Klopping C, Hulzebos EJ, de la Riviere AB, et al. Exercise performance in patients with endstage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting? J Am Coll Cardiol 200137:1794-9.
go back to reference Kemperman H, van den Berg M, Kirkels H, de Jonge N. B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP in patients with end-stage Heart failure supported by a left ventricular assist device. Clin Chem 2004;50;1670-2. Kemperman H, van den Berg M, Kirkels H, de Jonge N. B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP in patients with end-stage Heart failure supported by a left ventricular assist device. Clin Chem 2004;50;1670-2.
go back to reference Drews TN, Loebe M, Jurmann MJ, Weng Y, Wendelmuth C, Hetzer R. Outpatients on mechanical circulatory support. Ann Thor Surg 2003;75:780-5. Drews TN, Loebe M, Jurmann MJ, Weng Y, Wendelmuth C, Hetzer R. Outpatients on mechanical circulatory support. Ann Thor Surg 2003;75:780-5.
go back to reference El-Banayosy A, Fey O, Sarnowski P, Arusoglu L, Boethiq D, Milting H, et al. Midterm follow-up of patients discharged from hospital under left ventricular assistance. J Heart Lung Transplant 2001; 20:53-8. El-Banayosy A, Fey O, Sarnowski P, Arusoglu L, Boethiq D, Milting H, et al. Midterm follow-up of patients discharged from hospital under left ventricular assistance. J Heart Lung Transplant 2001; 20:53-8.
go back to reference McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 1998;115:904-12. McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 1998;115:904-12.
go back to reference Rose EA, Levin HR, Oz MC, et al. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation 1994;90;[suppl II]:II-87-91. Rose EA, Levin HR, Oz MC, et al. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation 1994;90;[suppl II]:II-87-91.
go back to reference Sinha P, Chen JM, Flannery M, Scully BE, Oz MC, Edwards MN. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 2000;102;[suppl III] III- 194-9. Sinha P, Chen JM, Flannery M, Scully BE, Oz MC, Edwards MN. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 2000;102;[suppl III] III- 194-9.
go back to reference Holman WL, Murrah CP, Ferguson ER, Bourge RC, McGriffin DC, Kirklin JK. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989-1994. Ann Thorac Surg 1996;61:366-71. Holman WL, Murrah CP, Ferguson ER, Bourge RC, McGriffin DC, Kirklin JK. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989-1994. Ann Thorac Surg 1996;61:366-71.
go back to reference Prendergast TW, Todd BA, Beyer AJ 3rd, Furukawa S, Eisen HJ, Addonizio VP, et al. Management of left ventricular assist device infection with Heart transplantation. Ann Thorac Surg 1997;64: 142-7. Prendergast TW, Todd BA, Beyer AJ 3rd, Furukawa S, Eisen HJ, Addonizio VP, et al. Management of left ventricular assist device infection with Heart transplantation. Ann Thorac Surg 1997;64: 142-7.
go back to reference El-Banayosy A, Arusoglu L, Kizner L, Tenderich G, Minami K, Inoue K, et al. Novacor left ventricular assist system versus Heart- Mate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 2000;119:581-7. El-Banayosy A, Arusoglu L, Kizner L, Tenderich G, Minami K, Inoue K, et al. Novacor left ventricular assist system versus Heart- Mate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 2000;119:581-7.
go back to reference Grady KL, Meyer PM, Dressler D, White-Williams C, Kaan A, Mattea A, et al. Change in quality of life from before to after discharge post left ventricular assist device implantation. J Heart Lung Transplant 2003;22:322-33. Grady KL, Meyer PM, Dressler D, White-Williams C, Kaan A, Mattea A, et al. Change in quality of life from before to after discharge post left ventricular assist device implantation. J Heart Lung Transplant 2003;22:322-33.
go back to reference Dew MA, Kormos RL, Winowich S, Harris RC, Stanford EA, Carozza L, Griffith BP. Quality of life outcomes in left ventricular assist system inpatients and outpatients. ASAIO J 1999;45:218-25. Dew MA, Kormos RL, Winowich S, Harris RC, Stanford EA, Carozza L, Griffith BP. Quality of life outcomes in left ventricular assist system inpatients and outpatients. ASAIO J 1999;45:218-25.
Metagegevens
Titel
End-stage heart failure and mechanical circulatory support: feasibility of discharge from hospital
Auteurs
A. Oosterom
N. de Jonge
J. H. Kirkels
B. F. M. Rodermans
E. Sukkel
C. Klöpping
F. Ramjankhan
J. R. Lahpor
Publicatiedatum
01-02-2007
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 2/2007
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03085953

Andere artikelen Uitgave 2/2007

Netherlands Heart Journal 2/2007 Naar de uitgave